Latest News From Lumira Ventures

enGene Expands Senior Management Team

Jennifer Schram enGene, Portfolio News

BOSTON and MONTRÉAL /PRNewswire/ – enGene Inc., the biotechnology company developing rationally designed gene therapies targeted to mucosal tissues through its proprietary non-viral vector DDX® platform, today announced the appointments of Sharon Tan as Vice President and Head of Program Management, and Lance …

Lumira announces investment in enGene Inc.

admin enGene, Portfolio News

TORONTO, ONTARIO — enGene Inc., a pre-clinical stage biopharmaceutical company developing a platform technology for the robust delivery of nucleotides (DNA or RNA) to the gut, announced today that it has completed an initial closing of a $13.25 million financing …